Rational design of effective therapy combining irinotecan and rapamycin to target mTOR/HIF-1 alpha axis in colon cancer

被引：0
|
作者：
Pencreach, E. [1 ]
Arrive, M. [1 ]
Raffelsberger, W. [2 ]
Lelong-Rebel, I. [3 ]
Larsen, A. K. [4 ]
Gaub, M. P. [1 ]
Guenot, D. [1 ]
Guerin, E. [1 ]
机构：
[1] INSERM, U682, Mol Biol Lab, Strasbourg, France
[2] IGBMC, Integrat Bioinformat Dept, Strasbourg, France
[3] CNRS, EA ULP 3430, Strasbourg, France
[4] INSERM, U893, Paris, France
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72527-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 39 条
  • [21] Inhibition of dipeptidyl peptidase-4 induces breast cancer autophagy to promote cell survival via mTOR/ HIF-1α axis
    Kawakita, Emi
    CANCER SCIENCE, 2023, 114 : 1580 - 1580
  • [22] Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
    Woo, Yu Mi
    Shin, Yubin
    Lee, Eun Ji
    Lee, Sunyoung
    Jeong, Seung Hun
    Kong, Hyun Kyung
    Park, Eun Young
    Kim, Hyoung Kyu
    Han, Jin
    Chang, Minsun
    Park, Jong-Hoon
    PLOS ONE, 2015, 10 (07):
  • [23] Combination therapy targeting hypoxia inducible factor-α ( HIF-1 α) and Tissue Factor (TF) by the mTOR inhibitor Rapamycin and the histone deacetylase inhibitor LBH589
    Verheul, Henk M. W.
    Qian, David Z.
    Van Erp, Karen
    Salumbides, Brenda
    Sanni, Tolib
    Atadja, Peter
    Pili, Roberto
    CANCER RESEARCH, 2006, 66 (08)
  • [24] THE HIF-1 TARGET LYSYL OXIDASE PROMOTES SURVIVAL AND OUTGROWTH OF COLON CANCER CELLS IN THE BONE MARROW ENABLING BONE METASTASIS FORMATION
    Reynaud, Caroline
    Ferreras, Laura
    Clezardin, Philippe
    ANTICANCER RESEARCH, 2014, 34 (10) : 6134 - 6134
  • [25] HIF-1 dependent reversal of cisplatin resistance via anti-oxidative nano selenium for effective cancer therapy
    Zhang, Xiaojuan
    He, Chuanchuan
    Yan, Ruicong
    Chen, Yan
    Zhao, Pengxuan
    Li, Minsi
    Fan, Ting
    Yang, Tan
    Lu, Yao
    Luo, Jun
    Ma, Xiang
    Xiang, Guangya
    CHEMICAL ENGINEERING JOURNAL, 2020, 380
  • [26] Efficient targeting of HIF-1α mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy
    Azar Bakand
    Sevil Vaghefi Moghaddam
    Maryam Naseroleslami
    Helder André
    Neda Mousavi-Niri
    Effat Alizadeh
    Journal of Biological Engineering, 17
  • [27] Efficient targeting of HIF-1α mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy
    Bakand, Azar
    Moghaddam, Sevil Vaghefi
    Naseroleslami, Maryam
    Andre, Helder
    Mousavi-Niri, Neda
    Alizadeh, Effat
    JOURNAL OF BIOLOGICAL ENGINEERING, 2023, 17 (01)
  • [28] Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells
    Huang, Jinling
    Gao, Likun
    Li, Bingshu
    Liu, Cheng
    Hong, Shasha
    Min, Lie
    Hong, Li
    MEDICAL SCIENCE MONITOR, 2019, 25 : 4250 - 4263
  • [29] Design, synthesis, and screening of novel ursolic acid derivatives as potential anti-cancer agents that target the HIF-1α pathway
    Wu, Jie
    Zhang, Zhi-Hong
    Zhang, Lin-Hao
    Jin, Xue-Jun
    Ma, Juan
    Piao, Hu-Ri
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (06) : 853 - 858
  • [30] Rg3 inhibits hypoxia-induced tumor exosomes from boosting pancreatic cancer vasculogenic mimicry through the HIF-1α/LARS1/mTOR axis
    Zhao, Tingting
    Cai, Xufan
    Chen, Hui
    Wang, Zhaohong
    Bu, Heqi
    Lin, Shengzhang
    PHYTOMEDICINE, 2025, 139
1234